Cargando…
Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
One of the most effective treatments for diabetes is to design a glucose-regulated insulin (INS) delivery system that could adjust the INS release time and rate to reduce diabetes-related complications. Here, mixed multiple layer-by-layer (mmLbL)-INS microspheres were developed for glucose-mediated...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557070/ https://www.ncbi.nlm.nih.gov/pubmed/36246353 http://dx.doi.org/10.3389/fbioe.2022.996763 |
_version_ | 1784807219891535872 |
---|---|
author | Yang, Yanguang Wang, Xiangqian Yuan, Xiaopeng Zhu, Qiwei Chen, Shusen Xia, Donglin |
author_facet | Yang, Yanguang Wang, Xiangqian Yuan, Xiaopeng Zhu, Qiwei Chen, Shusen Xia, Donglin |
author_sort | Yang, Yanguang |
collection | PubMed |
description | One of the most effective treatments for diabetes is to design a glucose-regulated insulin (INS) delivery system that could adjust the INS release time and rate to reduce diabetes-related complications. Here, mixed multiple layer-by-layer (mmLbL)-INS microspheres were developed for glucose-mediated INS release and an enhanced hypoglycemic effect for diabetes care. To achieve ultrafast glucose-activated INS release, glucose oxidase (GOx) was assembled with a positively charged polymer and modified on INS LbL. The mmLbL-INS microspheres were constructed with one, two, and four layers of the polyelectrolyte LbL assembly at a ratio of 1:1:1. Under hyperglycemia, GOx converts a change in the hyperglycemic environment to a pH stimulus, thus providing sufficient hydrogen ion. The accumulated hydrogen ion starts LbL charge shifting, and anionic polymers are converted to cationic polymers through hydrolytic cleavage of amine-functionalized side chains. The results of in vitro INS release suggested that glucose can modulate the mmLbL-INS microspheres in a pulsatile profile. In vivo studies validated that this formulation enhanced the hypoglycemic effect in STZ-induced diabetic rats within 2 h of subcutaneous administration and facilitated stabilization of blood glucose levels for up to 2 days. This glucose-activatable LbL microsphere system could serve as a powerful tool for constructing a precisely controlled release system. |
format | Online Article Text |
id | pubmed-9557070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95570702022-10-14 Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care Yang, Yanguang Wang, Xiangqian Yuan, Xiaopeng Zhu, Qiwei Chen, Shusen Xia, Donglin Front Bioeng Biotechnol Bioengineering and Biotechnology One of the most effective treatments for diabetes is to design a glucose-regulated insulin (INS) delivery system that could adjust the INS release time and rate to reduce diabetes-related complications. Here, mixed multiple layer-by-layer (mmLbL)-INS microspheres were developed for glucose-mediated INS release and an enhanced hypoglycemic effect for diabetes care. To achieve ultrafast glucose-activated INS release, glucose oxidase (GOx) was assembled with a positively charged polymer and modified on INS LbL. The mmLbL-INS microspheres were constructed with one, two, and four layers of the polyelectrolyte LbL assembly at a ratio of 1:1:1. Under hyperglycemia, GOx converts a change in the hyperglycemic environment to a pH stimulus, thus providing sufficient hydrogen ion. The accumulated hydrogen ion starts LbL charge shifting, and anionic polymers are converted to cationic polymers through hydrolytic cleavage of amine-functionalized side chains. The results of in vitro INS release suggested that glucose can modulate the mmLbL-INS microspheres in a pulsatile profile. In vivo studies validated that this formulation enhanced the hypoglycemic effect in STZ-induced diabetic rats within 2 h of subcutaneous administration and facilitated stabilization of blood glucose levels for up to 2 days. This glucose-activatable LbL microsphere system could serve as a powerful tool for constructing a precisely controlled release system. Frontiers Media S.A. 2022-09-29 /pmc/articles/PMC9557070/ /pubmed/36246353 http://dx.doi.org/10.3389/fbioe.2022.996763 Text en Copyright © 2022 Yang, Wang, Yuan, Zhu, Chen and Xia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Yang, Yanguang Wang, Xiangqian Yuan, Xiaopeng Zhu, Qiwei Chen, Shusen Xia, Donglin Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care |
title | Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care |
title_full | Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care |
title_fullStr | Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care |
title_full_unstemmed | Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care |
title_short | Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care |
title_sort | glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557070/ https://www.ncbi.nlm.nih.gov/pubmed/36246353 http://dx.doi.org/10.3389/fbioe.2022.996763 |
work_keys_str_mv | AT yangyanguang glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare AT wangxiangqian glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare AT yuanxiaopeng glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare AT zhuqiwei glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare AT chenshusen glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare AT xiadonglin glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare |